Lichtheimia corymbifera Colonization Leading to Pulmonary Infection Can Be Prevented with Liposomal Amphotericin B in a New Murine Model | Zendy

Thomas Brunet | Zendy; Kévin Brunet | Zendy; Grégory Jouvion | Zendy; Estelle Cateau | Zendy; Sandrine Marchand | Zendy; Blandine Rammaert | Zendy

Open Access

Lichtheimia corymbifera Colonization Leading to Pulmonary Infection Can Be Prevented with Liposomal Amphotericin B in a New Murine Model

Author(s) -

Thomas Brunet,

Kévin Brunet,

Grégory Jouvion,

Estelle Cateau,

Sandrine Marchand,

Blandine Rammaert

Publication year - 2019

Publication title -

antimicrobial agents and chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.07

H-Index - 259

eISSN - 1070-6283

pISSN - 0066-4804

DOI - 10.1128/aac.02544-18

Subject(s) - mucormycosis , amphotericin b , lung , cyclophosphamide , medicine , mycosis , zygomycosis , immunosuppression , pharmacology , chemotherapy , biology , immunology , microbiology and biotechnology , antifungal , surgery

The incidence of pulmonary mucormycosis is constantly increasing, especially in hematological patients staying in high-efficiency particulate air-filtered rooms. Pulmonary inhalation of spores may occur outside the hospital, leading to invasive disease once patients received chemotherapies.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research